CXCL2, a new critical factor and therapeutic target for cardiovascular diseases

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Previous studies have shown that inflammatory chemokines are involved in the physiological functions of cytoskeletal reorganization, cell migration, adhesion and immune responses. However, in the past decade, there have been st...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental hypertension (1993) 2020-07, Vol.42 (5), p.428-437
Main Authors: Guo, Lin-Ya, Yang, Fang, Peng, Li-Jun, Li, Yan-Bing, Wang, Ai-Ping
Format: Article
Language:English
Subjects:
atherosclerosis
cardiovascular disease
CXCL2
inflammation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Previous studies have shown that inflammatory chemokines are involved in the physiological functions of cytoskeletal reorganization, cell migration, adhesion and immune responses. However, in the past decade, there have been studies showing that inflammatory chemokines play a key role in CVD. Importantly, CXC motif chemokine ligand 2 (CXCL2) has been shown to be involved in the pathogenesis of cardiovascular disease. CXCL2 exerts its effects on the cardiovascular system by mediating inflammatory responses, but the specific signaling pathways by which CXCL2 exerts its effects in CVD remain unknown and need to be further investigated. This review aims to investigate the expression changes of CXCL2 in acute myocardial infarction (AMI), atherosclerosis (AS), obesity, diabetes and ischemic stroke (IS) and its potential key role in cardiovascular disease in order to provide new ideas for the prevention and treatment of cardiovascular diseases.
ISSN:1064-1963
1525-6006
DOI:10.1080/10641963.2019.1693585